Previous research has shown that reducing the n-6/n-3 ratio by increasing the consumption of n-3 fatty acids and/or reducing the intake of n-6 fatty acids can improve insulin sensitivity, decrease inflammation, and reduce the risk of developing NAFLD [39]. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.